Obesity Drugs Covered For Weight Loss Under Biden Proposal

Contributing sentiments towards policy:

55% : Medicare and Medicaid would pay without co-existing medical conditions if approved.
51% : The new obesity drugs, including Wegovy from Novo Nordisk and Zepbound from Eli Lilly, have been shown to improve health in numerous ways, but legislation passed 20 years ago prevents Medicare from covering drugs for "weight loss."The new proposal sidesteps that restriction, specifying that the drugs would be covered to treat the disease of obesity and prevent its related conditions.
50% : But it makes sense to get obesity under control before it creates diseases like diabetes -- which is now required before Medicare will cover the drugs.
29% : Via the New York Times:The Biden administration, in one of its last major policy directives, will propose that Medicare and Medicaid cover obesity medications, a costly and probably popular move that the Trump administration would need to endorse to become official.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.